approval
saveNURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 16, 2026 · 204d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalAug 1, 2025 · 431d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 12, 2024 · 663d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalApr 11, 2022 · 1639d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 31, 2022 · 1650d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 8, 2021 · 1763d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMay 27, 2021 · 1958d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalAug 18, 2020 · 2240d ago
same company · ±60 days · 6
- recallAspen Biopharma Labs Pvt., Ltd. recall (Cls II)Mar 19, 2025
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalFeb 21, 2025
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalFeb 21, 2025
- approvallorlatinib: LORBRENA (LORLATINIB) — FDA approvalFeb 18, 2025
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 12, 2025
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalJan 31, 2025
comments(0)
5-min edit window · permanent after that